Asahi Kasei Corporation

AHKSF·OTC Markets OTCPK·Industrials
Compare
10.300.00 (0.00%)today
At close: Oct 16, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close10.30
Open10.30
Day range10.2910.30
52-week range7.6011.84
Off day high0.00%
Off 52-week high−13.01%
Volume20.40K
Avg. volume (3M)492
Market cap13.74B
EPS (TTM)0.9200
Forward P/E—
P/E ratio (TTM)11.20
Dividend yield2.70% (0.2800)
Beta (5Y)0.66
Shares outstanding1.33B
Short interest—
Earnings dateNov 5, 2026
Analyst target—
Profit margin6.10%

Against its peers

Compare in full ›
AHKSF 6971.T 8058.T KAI NPO KRN.VI
Market cap 13.74B 4.64T 17.44T 3.12B 5.95B 3.54B
P/E (TTM) 11.2 35.6 19.9 28.4 136.4 12.1
Forward P/E — 40.8 22.5 19.5 25.8 —
Price/book 1.0 1.4 1.8 3.0 3.7 1.6
Dividend yield 2.70% 1.54% 2.67% 0.55% 0.46% 2.48%
1-year change +27.95% +76.68% +29.91% −12.69% +20.10% −9.62%
Today 0.00% +0.74% +0.74% +2.10% −1.01% −0.71%

The closest companies by business and industry (Conglomerates). Prices may be delayed up to 20 min.

Latest news

All AHKSF news ›
The Globe and Mail·Negative

Goldman Sachs downgrades Asahi Kasei (AHKSF) to a Hold

The Globe and Mail Goldman Sachs analyst downgraded Asahi Kasei to a Hold on October 8 and set a price target of Yen2,010.00. The company’s shares closed last Thursday at Yen1,650.50. The word on The Street in general, suggests a Moderate…

pharmaphorum·Positive

Aicuris acquisition delivers new drug for Asahi Kasei

Asahi Kasei's $920 million takeover of German biotech Aicuris in April has paid off with FDA approval for the herpes simplex virus (HSV) drug at the heart of the deal. The oral drug, called Hovilpri (pritelivir), has been cleared for…

Mugglehead·Positive

Asahi Kasei wins FDA approval for HOVILPRI in refractory HSV

The oral drug's label covers immunocompromised adults whose lesions failed standard antivirals, with U.S. availability expected before the end of 2026. An oral treatment for refractory herpes simplex lesions won U.S. approval on Friday as…

From articles in the 4Search news index.

In the news

11mentions in 30 days
11with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.